Litcius/Paper detail

Apoptosis, necroptosis, and pyroptosis as alternative cell death pathways induced by chemotherapeutic agents?

Adrianna Gielecińska, Mateusz Kciuk, Esam Bashir Yahya, Tarik Ainane, Somdutt Mujwar, Renata Kontek

2023Biochimica et Biophysica Acta (BBA) - Reviews on Cancer90 citationsDOIOpen Access PDF

Abstract

For decades, common chemotherapeutic drugs have been established to trigger apoptosis, the preferred immunologically "silent" form of cell death. The primary objective of this review was to show that various FDA-approved chemotherapeutic drugs, including cisplatin, cyclosporine, doxorubicin, etoposide, 5-fluorouracil, gemcitabine, paclitaxel, or vinblastine can trigger necroptosis and pyroptosis. We aimed to provide the advantages and disadvantages of the induction of the given type of cell death by chemotherapeutical agents. Moreover, we give a short overview of the molecular mechanism of each type of cell death and indicate the existing crosstalks between cell death types. Finally, we provide a comparison of cell death types to facilitate the exploration of cell death types induced by other chemotherapeutical agents. Understanding the cell death pathway induced by a drug can lessen side effects and assist the discovery of new combinations with synergistic effects and low systemic toxicity.

Topics & Concepts

NecroptosisPyroptosisProgrammed cell deathApoptosisVinblastineImmunogenic cell deathEtoposideGemcitabinePharmacologyCisplatinMedicineCancer researchBiologyChemotherapySurgeryBiochemistryCell death mechanisms and regulationInflammasome and immune disordersPARP inhibition in cancer therapy